Baxter International INC Form 4 insider transactions

Director Stephen H. Rusckowski reports acquisition of Baxter International shares through a stock grant and dividend reinvestment.

Director Stephen N. Oesterle reports acquisition of Baxter International shares through a grant and dividend reinvestment.

Director Patricia Morrison reported receiving a grant of Baxter International Inc. common stock and updated her beneficial ownership.

Director William A. Ampofo II reports acquisition of Baxter International shares through a grant and dividend reinvestment, and disposition of shares.

Director Jeffrey A. Craig reports acquisition of Baxter International shares through a grant and dividend reinvestment, and disposition of shares.

Anita A. Zielinski, SVP, CAO and Controller of Baxter International, reports the acquisition of 17,123 restricted stock units.

Alok Sonig, EVP, Group President, Pharma at Baxter International, reports the acquisition and disposal of company stock and stock options on March 6, 2025.

David S. Rosenbloom, EVP and General Counsel of Baxter International, reports the acquisition and disposal of company stock and stock options on March 6, 2025.

EVP Reazur Rasul reports acquisition and disposal of Baxter International stock and stock options on March 6, 2025.

Jeanne K. Mason, EVP and Chief HR Officer of Baxter International, reports the acquisition and disposal of company stock and stock options on March 6, 2025.

EVP and Chief Operating Officer of Baxter International, Heather Knight, reports acquisition and disposal of company stock and stock options.

Joel T. Grade, EVP and CFO of Baxter International, reports acquisition and disposal of common stock and stock options on March 6, 2025.

EVP James W. Borzi reports acquisition and disposal of Baxter International stock and stock options.

David S. Rosenbloom, EVP and General Counsel of Baxter International, reports a transaction involving common stock to cover tax withholding related to vested restricted stock units.

Alok Sonig, EVP, Group President, Pharma at Baxter International, disposed of shares to cover tax withholding obligations related to vested restricted stock units.

EVP Reazur Rasul forfeited 1,987 shares of Baxter International stock on March 3, 2025, to cover tax withholding related to the vesting of restricted stock units.

EVP and Chief HR Officer of Baxter International, Jeanne K. Mason, reports changes in beneficial ownership due to tax withholding related to vested restricted stock units.

EVP and Chief Operating Officer of Baxter International, Heather Knight, reports disposing of shares to cover tax obligations related to vested restricted stock units.

EVP and Chief Supply Chain Officer of Baxter International, James W. Borzi, reports a transaction involving common stock related to vested restricted stock units.

David Brent Shafer, Interim CEO and Chair of Baxter International, reports the acquisition of restricted stock units and dividend reinvestment in common stock.

Christopher A. Toth, EVP at Baxter International, disposed of 25,372 shares to cover tax withholding related to the vesting of restricted stock units.

Christopher A. Toth, EVP, Group President, Kidney Care at Baxter International, reports disposition of shares to cover tax withholding upon vesting of restricted stock units.

Baxter International's CEO, Jose Almeida, forfeited 5,966 shares of common stock to cover taxes related to previously granted restricted stock units.

Executive Vice President of Baxter International, Reazur Rasul, reported a transaction involving the forfeiture of 2,032 shares to cover tax withholdings.

Executive Vice President Heather Knight of Baxter International reported the forfeiture of 6,041 shares to cover taxes related to vested stock units.

Baxter International's CFO, Joel T. Grade, forfeited 6,612 shares to cover taxes related to vested restricted stock units.

Director Jeffrey A. Craig acquired 3,472 shares of Baxter International Inc. common stock on September 9, 2024, as part of a grant.

Alok Sonig, EVP, Group President, Pharma at Baxter International, reports the forfeiture of 3,054 shares to cover tax withholding related to vested restricted stock units.

James W. Borzi, EVP and Chief Supply Chain Officer at Baxter International, forfeited 1,685 shares to cover tax withholdings related to the vesting of restricted stock units.

Christopher A. Toth, EVP at Baxter International, disposed of shares to cover tax withholding obligations related to vested restricted stock units.